All News

Survivors find that physical activity and sound nutrition lower health risks and boost well-being.

From National Women's Health Week to today’s top athletes, here’s what’s making headlines in the cancer space this week.

With the growing price of cancer treatment, researchers evaluated the cost-effectiveness of the new standard-of-care in frontline metastatic renal cell carcinoma.

The phase 3 CheckMate 498 trial, designed to compare Opdivo with Temodal for the treatment of patients with newly diagnosed O6-methylguanine-DNA methyltransferase (MGMT)-unmethylated glioblastoma multiforme failed to meet its primary endpoint of increasing overall survival.

Mixing cancer and bipolar illness is not a winning cocktail in the long-term health care industry.

Breast cancer survivors may find symptom relief through at-home acupressure, according to study findings.

A second ovarian cancer recurrence in three years prompted this review of lessons learned. If I could go back three and a half years and give advice to my newly diagnosed self, what would I say?

Treatment with bb2121 showed promising efficacy and safety among heavily pretreated patients with multiple myeloma, according to interim results published in the New England Journal of Medicine.

Two husbands embrace changing and challenging roles at home when they learn of their spouses’ cancer diagnoses.

How does attitude affect a diagnosis of cancer? Does a positive attitude prolong a person’s life? Does a negative attitude make cancer grow? This survivor discusses how attitude affects cancer in a person’s life.

The Bruton tyrosine kinase inhibitor showed a statistically-significant and clinically-meaningful improvement in progression-free survival in patients with previously-treated CLL.

At 42,000 US deaths a year, the push to call metastatic breast cancer "chronic" is premature.

A generous donor will match every donation up to $100,000 to the Tyler Trent Fund.

Funds raised to support cancer research in Virginia, nationwide.

Vision Boards are both therapeutic and fun for cancer survivors and everyone else!

The FDA approved Kadcyla for adjuvant treatment of patients with HER2-positive early breast cancer who have residual invasive disease after neoadjuvant taxane and Herceptin-based treatment.

From an FDA decision to keep textured breast implants on the market to TV personalities and politicians, here’s what’s making headlines in the cancer space this week.

Most people have heard the term "new normal" for individuals living, surviving and struggling with cancer. What actually does that mean?

Lack of awareness and knowledge of early-onset colorectal cancer is a problem, but early messaging can help combat the issue.

Surveillance guidelines for hereditary colorectal cancer may be more effective in preventing the disease compared with those intended for individuals with a family history.

The FDA has approved a supplemental new drug application for Tibsovo as a single agent for the first-line treatment of adult patients with IDH1-mutant acute myeloid leukemia who are 75 years and older or are ineligible to receive intensive chemotherapy.

I don't know why my fear is bigger right now than the reality that I was a rock-star-warrior during the biggest, deepest, most tortuous experience of my life: cancer.

Stuck in his own fear. How needle-phobia kept this cancer survivor pinned down.

Walgreens expands health and beauty support program for patients with cancer.

In this week’s episode, we spoke with the founder of Imerman Angels on providing personalized connections to enable one-on-one support among cancer fighters, survivors and caregivers.

There are currently more than 700 new therapies in development for people with cancer, representing a trend that is being driven by increased innovation.

More and more patients are being offered palliative, or supportive, care, and this is a welcomed trend.

Here are the top 5 CURE stories for April 2019.

Researchers examined the prevalence of chronic opioid use among survivors of breast, colorectal and lung cancer.

Only half of patients reported their blood cancer was detected while visiting a doctor after experiencing symptoms versus detection during a routine medical test or exam or while under the care of a doctor for another health condition.